(Q46211908)

English

Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Fabio Mangiacapra

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

Emanuele Barbato

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

object named as

William Wijns

3

0 references

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

32

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

54-58

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

https://scigraph.springernature.com/pub.10.1007/s11239-010-0547-4

0 references

The platelet in diabetes: focus on prevention of ischemic events

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Factors contributing to increased platelet reactivity in people with diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0547-4

21 January 2018

Standards of medical care in diabetes--2006

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221715

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221715

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-010-0547-4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21221715

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46211908&oldid=2099914008"